| Malignant hyperthermia: a review H Rosenberg, N Pollock, A Schiemann, T Bulger, K Stowell Orphanet journal of rare diseases 10, 1-19, 2015 | 598 | 2015 |
| Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter M Crossley, M Ludwig, KM Stowell, P De Vos, K Olek, GG Brownlee Science 257 (5068), 377-379, 1992 | 172 | 1992 |
| Malignant hyperthermia associated with exercise‐induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian … M Davis, R Brown, A Dickson, H Horton, D James, N Laing, R Marston, ... British Journal of Anaesthesia 88 (4), 508-515, 2002 | 136 | 2002 |
| A novel ryanodine receptor mutation and genotype–phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree RL Brown, AN Pollock, KG Couchman, M Hodges, DO Hutchinson, ... Human Molecular Genetics 9 (10), 1515-1524, 2000 | 123 | 2000 |
| Expression of cloned human lactoferrin in baby-hamster kidney cells KM Stowell, TA Rado, WD Funk, JW Tweedie Biochemical Journal 276 (2), 349-355, 1991 | 115 | 1991 |
| Studies of the N-terminal half of human lactoferrin produced from the cloned cDNA demonstrate that interlobe interactions modulate iron release. CL Day, KM Stowell, EN Baker, JW Tweedie Journal of Biological Chemistry 267 (20), 13857-13862, 1992 | 100 | 1992 |
| The use of PCR to detect Neospora caninum DNA in the blood of naturally infected cows CM Okeoma, NB Williamson, WE Pomroy, KM Stowell, L Gillespie Veterinary parasitology 122 (4), 307-315, 2004 | 86 | 2004 |
| Malignant hyperthermia in infancy and identification of novel RYR1 mutation D Chamley, NA Pollock, KM Stowell, RL Brown British journal of Anaesthesia 84 (4), 500-504, 2000 | 81 | 2000 |
| Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility JJ Johnston, RT Dirksen, T Girard, SG Gonsalves, PM Hopkins, S Riazi, ... Genetics in Medicine 23 (7), 1288-1295, 2021 | 61 | 2021 |
| Malignant hyperthermia: a pharmacogenetic disorder KM Stowell Pharmacogenomics 9 (11), 1657-1672, 2008 | 61 | 2008 |
| DNA testing for malignant hyperthermia: the reality and the dream KM Stowell Anesthesia & Analgesia 118 (2), 397-406, 2014 | 60 | 2014 |
| Neospora caninum: quantification of DNA in the blood of naturally infected aborted and pregnant cows using real-time PCR CM Okeoma, KM Stowell, NB Williamson, WE Pomroy Experimental parasitology 110 (1), 48-55, 2005 | 52 | 2005 |
| Identification of ryanodine receptor 1 single-nucleotide polymorphisms by high-resolution melting using the LightCycler 480 System H Grievink, KM Stowell Analytical Biochemistry 374 (2), 396-404, 2008 | 50 | 2008 |
| Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia AH Schiemann, KM Stowell BJA: British Journal of Anaesthesia 117 (1), 124-128, 2016 | 49 | 2016 |
| Isolation and molecular characterisation of Neospora caninum in cattle in New Zealand CM Okeoma, NB Williamson, WE Pomroy, KM Stowell, LM Gillespie New Zealand Veterinary Journal 52 (6), 364-370, 2004 | 47 | 2004 |
| Suspected malignant hyperthermia reactions in New Zealand AN Pollock, EE Langton, K Couchman, KM Stowell, M Waddington Anaesthesia and intensive care 30 (4), 453-461, 2002 | 46 | 2002 |
| Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia AA Anderson, RL Brown, B Polster, N Pollock, KM Stowell The Journal of the American Society of Anesthesiologists 108 (2), 208-215, 2008 | 45 | 2008 |
| GcSTUA, an APSES Transcription Factor, Is Required for Generation of Appressorial Turgor Pressure and Full Pathogenicity of Glomerella cingulata XZ Tong, X Zhang, KM Plummer, KM Stowell, PA Sullivan, PC Farley Molecular plant-microbe interactions 20 (9), 1102-1111, 2007 | 43 | 2007 |
| Expression and role in glycolysis of human ADP-dependent glucokinase S Richter, JP Richter, SY Mehta, AM Gribble, AJ Sutherland-Smith, ... Molecular and cellular biochemistry 364, 131-145, 2012 | 39 | 2012 |
| Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells N Magan, RJ Isaacs, KM Stowell Anti-cancer drugs 23 (6), 627-637, 2012 | 38 | 2012 |
